<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24-pharmaceuticals-12-00101">
 <label>24.</label>
 <element-citation publication-type="web">
  <person-group person-group-type="author">
   <collab>BioCryst Pharmaceuticals Inc.</collab>
  </person-group>
  <article-title>BioCrystâ€™s Partner Shinogi Receives Approval for Pediatric Use of Peramivir in Japan</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="http://investor.shareholder.com/biocryst/releasedetail.cfm?releaseid=523371" xmlns:xlink="http://www.w3.org/1999/xlink">http://investor.shareholder.com/biocryst/releasedetail.cfm?releaseid=523371</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2011-11-02">(accessed on 2 November 2011)</date-in-citation>
 </element-citation>
</ref>
